Conformis Inc.

0.3390+0.0440+14.92%Vol 2.66M1Y Perf -78.15%
Aug 11th, 2022 16:00 DELAYED
BID0.3300 ASK0.3550
Open0.2957 Previous Close0.2950
Pre-Market- After-Market0.34
 - -  - -%
Target Price
1.88 
Analyst Rating
Strong Buy 1.00
Potential %
454.57 
Finscreener Ranking
★★★★+     56.84
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★+     57.85
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     50.47
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
5.16 
Earnings Rating
Sell
Market Cap63.73M 
Earnings Date
8th Aug 2022
Alpha-0.02 Standard Deviation0.31
Beta1.46 

Today's Price Range

0.29290.3644

52W Range

0.25101.96

5 Year PE Ratio Range

-1.80-2.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
21.07%
1 Month
-0.15%
3 Months
-0.35%
6 Months
-45.44%
1 Year
-78.15%
3 Years
-80.40%
5 Years
-90.56%
10 Years
-

TickerPriceChg.Chg.%
CFMS0.33900.044014.92
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
ProfitabilityValueIndustryS&P 500US Markets
64.20
-3.40
0.80
-58.40
-91.37
RevenueValueIndustryS&P 500US Markets
45.23M
0.24
4.12
2.43
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.08-0.09-12.50
Q01 2022-0.07-0.09-28.57
Q04 2021-0.08-0.09-12.50
Q03 2021-0.07-0.070.00
Q02 20210.080.21162.50
Q01 2021-0.08-0.09-12.50
Q04 2020-0.11-0.0827.27
Q03 2020-0.12-0.0925.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.080.00-
9/2022 QR-0.070.00-
12/2022 FY-0.31-10.71Negative
12/2023 FY-0.27-17.39Negative
Next Report Date-
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.66M
Shares Outstanding188.00K
Shares Float179.78M
Trades Count3.48K
Dollar Volume887.29K
Avg. Volume1.48M
Avg. Weekly Volume2.46M
Avg. Monthly Volume1.14M
Avg. Quarterly Volume828.39K

Conformis Inc. (NASDAQ: CFMS) stock closed at 0.339 per share at the end of the most recent trading day (a 14.92% change compared to the prior day closing price) with a volume of 2.66M shares and market capitalization of 63.73M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 271 people. Conformis Inc. CEO is Mark A. Augusti.

The one-year performance of Conformis Inc. stock is -78.15%, while year-to-date (YTD) performance is -55.48%. CFMS stock has a five-year performance of -90.56%. Its 52-week range is between 0.251 and 1.955, which gives CFMS stock a 52-week price range ratio of 5.16%

Conformis Inc. currently has a PE ratio of -6.80, a price-to-book (PB) ratio of 0.59, a price-to-sale (PS) ratio of 1.17, a price to cashflow ratio of 27.70, a PEG ratio of 2.32, a ROA of -5.20%, a ROC of -4.29% and a ROE of -8.24%. The company’s profit margin is -91.37%, its EBITDA margin is 0.80%, and its revenue ttm is $45.23 Million , which makes it $0.24 revenue per share.

Of the last four earnings reports from Conformis Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Conformis Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Conformis Inc. is Strong Buy (1), with a target price of $1.88, which is +454.57% compared to the current price. The earnings rating for Conformis Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conformis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Conformis Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.53, ATR14 : 0.03, CCI20 : 278.68, Chaikin Money Flow : -0.36, MACD : -0.01, Money Flow Index : 76.44, ROC : 24.63, RSI : 54.90, STOCH (14,3) : 77.60, STOCH RSI : 1.00, UO : 47.02, Williams %R : -22.40), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conformis Inc. in the last 12-months were: Mark A. Augusti (Sold 137 598 shares of value $137 021 ), Robert S. Howe (Sold 11 537 shares of value $7 514 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Conformis Inc.

Conformis Inc is a US-based medical technology company. It uses iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of knee replacement market. Its total revenue generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.

CEO: Mark A. Augusti

Telephone: +1 781 345-9001

Address: 600 Technology Park Drive, Billerica 01821, MA, US

Number of employees: 271

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

49%51%


News

Stocktwits